Clinical Trial Update: International Registry for ASD Closure by Using the Occlutech®Flex II Device in More Than 2000 Patients

View source ↗

Summary

An international registry update evaluating ASD closure using the Occlutech Flex II device in over 2,000 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• Occlutech Flex II Device

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Atrial Septal Defect | Status: UNKNOWN